An invalid vocabulary is selected. Please change it in the options.
Title Credits Start date - Expiration date
Recorded Presentation from the NCCN Pharmacy Updates: Current Therapy Options for Graft-Versus-Host Disease 1.00 04/07/2020 - 12:00am to 04/01/2021 - 12:00am
NCCN Guidelines® Insights - Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020 1.00 04/10/2020 - 12:00am to 04/10/2021 - 12:00am
Talking to Patients about Cancer Treatment, Risk Factors, and Treatment Cessation during the COVID-19 Pandemic 1.00 04/20/2020 - 12:00am to 04/20/2021 - 12:00am
BCOP Test - New Targets and Treatment Options for Acute Myeloid Leukemia 04/28/2020 - 2:00pm to 04/28/2021 - 12:00am
Recorded Presentation from the NCCN Pharmacy Updates: New Targets and Treatment Options for Acute Myeloid Leukemia 1.00 04/30/2020 - 12:00am to 04/28/2021 - 12:00am
Practical Use of Next Generation Sequencing in Metastatic Disease 0.50 05/08/2020 - 12:00am to 03/01/2021 - 12:00am
Treatment Considerations in Older Adult Oncology 0.75 05/08/2020 - 12:00am to 03/01/2021 - 12:00am
Immune Checkpoint Inhibitor Toxicities 0.75 05/08/2020 - 12:00am to 03/01/2021 - 12:00am
The Role of Biosimilars in Cancer Treatment 0.75 05/08/2020 - 12:00am to 03/01/2021 - 12:00am
The Role of Integrative Medicine in Cancer 0.75 05/08/2020 - 12:00am to 03/01/2021 - 12:00am
Molecular Testing Updates and Impact for Clinical Practice 0.75 05/08/2020 - 12:00am to 03/01/2021 - 12:00am
NCCN Guidelines® Insights - Primary Cutaneous Lymphomas, Version 2.2020 1.00 05/10/2020 - 12:00am to 05/10/2021 - 12:00am
New Approaches to Multiple Myeloma Therapy 1.00 05/12/2020 - 12:00am to 05/12/2021 - 12:00am
Recognition and Management of Graft Versus Host Disease 1.00 05/12/2020 - 12:00am to 03/01/2021 - 12:00am
Current Insights: Evolving Principles and Controversies of Cancer Risk Assessment and Management of Hereditary Cancers 1.25 05/15/2020 - 12:00am to 03/01/2021 - 12:00am

Pages